Lennernäs H - Search Results

1

Extensive intestinal glucuronidation of raloxifene in vivo in pigs and impact for oral drug delivery.

Thörn HA, Yasin M, Dickinson PA, Lennernäs H. Thörn HA, et al. Among authors: lennernas h. Xenobiotica. 2012 Sep;42(9):917-28. doi: 10.3109/00498254.2012.683497. Epub 2012 May 4. Xenobiotica. 2012. PMID: 22559211

2

Regional gastrointestinal absorption of the beta-blocker pafenolol in the rat and intestinal transit rate determined by movement of 14C-polyethylene glycol (PEG) 4000.

Lennernäs H, Regårdh CG. Lennernäs H, et al. Pharm Res. 1993 Jan;10(1):130-5. doi: 10.1023/a:1018993501426. Pharm Res. 1993. PMID: 8094244

3

Presystemic elimination of the beta-blocker pafenolol in the rat after oral and intraperitoneal administration and identification of a main metabolite in both rats and humans.

Lennernäs H, Renberg L, Hoffmann KJ, Regårdh CG. Lennernäs H, et al. Drug Metab Dispos. 1993 May-Jun;21(3):435-40. Drug Metab Dispos. 1993. PMID: 8100498

4

Evidence for an interaction between the beta-blocker pafenolol and bile salts in the intestinal lumen of the rat leading to dose-dependent oral absorption and double peaks in the plasma concentration-time profile.

Lennernäs H, Regårdh CG. Lennernäs H, et al. Pharm Res. 1993 Jun;10(6):879-83. doi: 10.1023/a:1018965328626. Pharm Res. 1993. PMID: 8100633

5

Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation?

Lennernäs H. Lennernäs H. Pharm Res. 1995 Nov;12(11):1573-82. doi: 10.1023/a:1016220428705. Pharm Res. 1995. PMID: 8592653 Review.

6

Human intestinal permeability.

Lennernäs H. Lennernäs H. J Pharm Sci. 1998 Apr;87(4):403-10. doi: 10.1021/js970332a. J Pharm Sci. 1998. PMID: 9548891 Review.

7

Jejunal absorption and metabolism of R/S-verapamil in humans.

Sandström R, Karlsson A, Knutson L, Lennernäs H. Sandström R, et al. Among authors: lennernas h. Pharm Res. 1998 Jun;15(6):856-62. doi: 10.1023/a:1011916329863. Pharm Res. 1998. PMID: 9647350

8

The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique.

Tannergren C, Knutson T, Knutson L, Lennernäs H. Tannergren C, et al. Among authors: lennernas h. Br J Clin Pharmacol. 2003 Feb;55(2):182-90. doi: 10.1046/j.1365-2125.2003.01722.x. Br J Clin Pharmacol. 2003. PMID: 12580990 Free PMC article.

9

Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine.

Tannergren C, Petri N, Knutson L, Hedeland M, Bondesson U, Lennernäs H. Tannergren C, et al. Among authors: lennernas h. Clin Pharmacol Ther. 2003 Nov;74(5):423-36. doi: 10.1016/S0009-9236(03)00238-8. Clin Pharmacol Ther. 2003. PMID: 14586383 Clinical Trial.

10

Pharmacokinetics of gefitinib in humans: the influence of gastrointestinal factors.

Bergman E, Forsell P, Persson EM, Knutson L, Dickinson P, Smith R, Swaisland H, Farmer MR, Cantarini MV, Lennernäs H. Bergman E, et al. Among authors: lennernas h. Int J Pharm. 2007 Aug 16;341(1-2):134-42. doi: 10.1016/j.ijpharm.2007.04.002. Epub 2007 Apr 6. Int J Pharm. 2007. PMID: 17482782 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters